Application

Dox-NP^™(5mL vial) has been used as a sample to study its characteristics by asymmetrical-flow field flow fractionation (MD-AF4). It may also be used as an intravenous (i.v.) injection in flank or orthotopic animal models of cancer.

General description

Formulation: A Pegylated, long-circulating liposomal formulation with doxorubicin entrapped within an ammonium sulfate core via remote-loading. All unencapsulated was removed to yield a completely liposomal doxorubicin product. Liposomes are stored frozen for a longer shelf life.

Legal Information

Avanti is a registered trademark of Avanti Polar Lipids, Inc.

Dox-NP is a trademark of Avanti Polar Lipids, Inc.

Packaging

10 mL amber serum vial (300115S-1EA)